AMPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Amphastar Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 18.81 USD 2.17% Market Closed

Market Cap: $837.6m

	Amphastar Pharmaceuticals Inc NASDAQ:AMPH	US
	Stronghold Digital Mining Inc NASDAQ:SDIG	US
	Seek Ltd ASX:SEK	AU
A	American Lithium Corp NASDAQ:AMLI	CA
	Tupperware Brands Corp NYSE:TUP	US

Profitability Summary

Amphastar Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Strong 3Y Average Gross Margin

52%

Declining Gross Margin

51% > 49%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

27%

Declining Operating Margin

23% > 20%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

18% > 14%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

21%

Free Cash Flow Margin is Increasing

10% > 17%

Positive ROE

13%

Positive 3Y Average ROE

Positive 3Y Average ROIC

14%

Declining ROIC

18% > 8%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.